AKT1 and COVID-19: In conclusion, we identified the pharmacological targets and the therapeutic mechanisms of curcumol in the treatment of COVID-19 and LUAD, including immune response, DNA damage response, and cell cycle arrest, and regulation of cell-signaling pathways such as the p53 signaling pathway, FoxO signaling pathway, and PI3K-Akt signaling pathway.